These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Somatic alterations, metabolizing genes and smoking in rectal cancer. Curtin K; Samowitz WS; Wolff RK; Herrick J; Caan BJ; Slattery ML Int J Cancer; 2009 Jul; 125(1):158-64. PubMed ID: 19358278 [TBL] [Abstract][Full Text] [Related]
4. PPARgamma and colon and rectal cancer: associations with specific tumor mutations, aspirin, ibuprofen and insulin-related genes (United States). Slattery ML; Curtin K; Wolff R; Ma KN; Sweeney C; Murtaugh M; Potter JD; Levin TR; Samowitz W Cancer Causes Control; 2006 Apr; 17(3):239-49. PubMed ID: 16489531 [TBL] [Abstract][Full Text] [Related]
5. Nutrients in folate-mediated, one-carbon metabolism and the risk of rectal tumors in men and women. Curtin K; Samowitz WS; Ulrich CM; Wolff RK; Herrick JS; Caan BJ; Slattery ML Nutr Cancer; 2011; 63(3):357-66. PubMed ID: 21462086 [TBL] [Abstract][Full Text] [Related]
6. Calcium, vitamin D, VDR genotypes, and epigenetic and genetic changes in rectal tumors. Slattery ML; Wolff RK; Herrick JS; Caan BJ; Samowitz W Nutr Cancer; 2010; 62(4):436-42. PubMed ID: 20432164 [TBL] [Abstract][Full Text] [Related]
7. Microsatellite instability and survival in rectal cancer. Samowitz WS; Curtin K; Wolff RK; Tripp SR; Caan BJ; Slattery ML Cancer Causes Control; 2009 Nov; 20(9):1763-8. PubMed ID: 19669908 [TBL] [Abstract][Full Text] [Related]
8. Assessing tumor mutations to gain insight into base excision repair sequence polymorphisms and smoking in colon cancer. Curtin K; Samowitz WS; Wolff RK; Ulrich CM; Caan BJ; Potter JD; Slattery ML Cancer Epidemiol Biomarkers Prev; 2009 Dec; 18(12):3384-8. PubMed ID: 19959686 [TBL] [Abstract][Full Text] [Related]
9. Colon tumor mutations and epigenetic changes associated with genetic polymorphism: insight into disease pathways. Slattery ML; Wolff RK; Curtin K; Fitzpatrick F; Herrick J; Potter JD; Caan BJ; Samowitz WS Mutat Res; 2009 Jan; 660(1-2):12-21. PubMed ID: 18992263 [TBL] [Abstract][Full Text] [Related]
10. IL6 genotypes and colon and rectal cancer. Slattery ML; Wolff RK; Herrick JS; Caan BJ; Potter JD Cancer Causes Control; 2007 Dec; 18(10):1095-105. PubMed ID: 17694420 [TBL] [Abstract][Full Text] [Related]
11. Antioxidants, carotenoids, and risk of rectal cancer. Murtaugh MA; Ma KN; Benson J; Curtin K; Caan B; Slattery ML Am J Epidemiol; 2004 Jan; 159(1):32-41. PubMed ID: 14693657 [TBL] [Abstract][Full Text] [Related]
12. Diet, physical activity, and body size associations with rectal tumor mutations and epigenetic changes. Slattery ML; Curtin K; Wolff RK; Herrick JS; Caan BJ; Samowitz W Cancer Causes Control; 2010 Aug; 21(8):1237-45. PubMed ID: 20383576 [TBL] [Abstract][Full Text] [Related]
13. KRAS mutations and CDKN2A promoter methylation show an interactive adverse effect on survival and predict recurrence of rectal cancer. Kohonen-Corish MR; Tseung J; Chan C; Currey N; Dent OF; Clarke S; Bokey L; Chapuis PH Int J Cancer; 2014 Jun; 134(12):2820-8. PubMed ID: 24259266 [TBL] [Abstract][Full Text] [Related]
14. Mutations in specific codons of the KRAS oncogene are associated with variable resistance to neoadjuvant chemoradiation therapy in patients with rectal adenocarcinoma. Duldulao MP; Lee W; Nelson RA; Li W; Chen Z; Kim J; Garcia-Aguilar J Ann Surg Oncol; 2013 Jul; 20(7):2166-71. PubMed ID: 23456389 [TBL] [Abstract][Full Text] [Related]
15. Rectal cancer profiling identifies distinct subtypes in India based on age at onset, genetic, epigenetic and clinicopathological characteristics. Laskar RS; Ghosh SK; Talukdar FR Mol Carcinog; 2015 Dec; 54(12):1786-95. PubMed ID: 25418895 [TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in insulin-related genes predispose to specific KRAS2 and TP53 mutations in colon cancer. Samowitz WS; Wolff RK; Ma KN; Andersen K; Caan B; Slattery ML Mutat Res; 2006 Mar; 595(1-2):117-24. PubMed ID: 16448675 [TBL] [Abstract][Full Text] [Related]
17. A comparison of colon and rectal somatic DNA alterations. Slattery ML; Curtin K; Wolff RK; Boucher KM; Sweeney C; Edwards S; Caan BJ; Samowitz W Dis Colon Rectum; 2009 Jul; 52(7):1304-11. PubMed ID: 19571709 [TBL] [Abstract][Full Text] [Related]
18. Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer. Ogino S; Kawasaki T; Kirkner GJ; Ogawa A; Dorfman I; Loda M; Fuchs CS J Pathol; 2006 Oct; 210(2):147-54. PubMed ID: 16850502 [TBL] [Abstract][Full Text] [Related]
19. Relative role of methylator and tumor suppressor pathways in ulcerative colitis-associated colon cancer. Sanchez JA; Dejulius KL; Bronner M; Church JM; Kalady MF Inflamm Bowel Dis; 2011 Sep; 17(9):1966-70. PubMed ID: 21618350 [TBL] [Abstract][Full Text] [Related]
20. CpG island methylator phenotype in colorectal cancers: comparison of the new and classic CpG island methylator phenotype marker panels. Lee S; Cho NY; Yoo EJ; Kim JH; Kang GH Arch Pathol Lab Med; 2008 Oct; 132(10):1657-65. PubMed ID: 18834226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]